NUMD — Nu-Med Plus Cashflow Statement
0.000.00%
- $6.18m
- $6.28m
Annual cashflow statement for Nu-Med Plus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.04 | -2.01 | -0.83 | -0.13 | -0.126 |
Depreciation | |||||
Non-Cash Items | 0.417 | 1.57 | 0.203 | -0.007 | 0.042 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.039 | 0.012 | 0.411 | 0.096 | 0.017 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -0.567 | -0.415 | -0.207 | -0.038 | -0.066 |
Capital Expenditures | 0 | — | — | — | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | 0 | — | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | 0 | — | — | — |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.407 | 0.596 | 0.03 | 0.1 | 0 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.16 | 0.181 | -0.177 | 0.062 | -0.066 |